Fruergaard leveraging experience from Danish partnerships in key roles in Brussels

Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.

(ARKIV) | Photo: Stine Bidstrup/ERH

Brussels – There will be Danish roots to be found in the life science sector’s undertakings in Brussels over the next year.

So says Chief Executive Officer of Novo Nordisk Lars Fruergaard Jørgensen in an interview with MedWatch after having been tapped to play several key roles for life science lobby European Federation of Pharmaceutical Industries and Associations in coming years.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs